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This study was undertaken to investigate the possible rela­
tionship of Extra-High Frequency (EHF) pure tone thresholds to 
the use of oral contraceptives. The procedure involved the de­
termination of auditory thresholds of 42 subjects for the fre­
quencies lOK, 12K, 14K, 16K, and 18K Hz using automatic audio­
metry. The subjects were divided into three groups as follows: 
(1) 14 women aged 18-28 years who have used oral contraceptives 
continuously for the last four or more years; (2) 14 women aged
18-28 years who have used oral contraceptives continuously for 
the last one-three years; (3) 14 women aged 18-28 years who have 
never used oral contraceptives. All subjects reported no history 
of excessive noise exposure and were required to pass a pure tone 
screening test bilaterally for the frequencies 2K, 4K, and 6K Hz. 
In addition, subjects were controlled for (a) smoking, (b) med­
ically restrictive diets such as low cholesterol or low sugar,
(c) reported elevated blood pressure, and (d) ototoxic drug 
usage.
The results of the study indicated no significant differences 
in EHF pure tone thresholds between subjects using oral contra­
ceptives and control subjects for any of the five Extra-High 
Frequencies tested. There was a general but statistically non­
significant trend for the group of women using oral contracep­
tives for the last four or more years to have higher mean EHF 
thresholds than the group of women using oral contraceptives 
for the last one-three years; however, neither group of oral 
contraceptive users demonstrated consistently higher EHF thres­
holds than the control group. The differences in results between 
this study and previous investigations of the relationship of 
EHF thresholds to elevated blood lipids and various blood clot­
ting components were discussed in terms of the differences in 
subject selection and experimental procedures. It was concluded 
that the use of oral contraceptives does not appear to signifi­
cantly affect, as a group, the EHF hearing acuity of normal 
women aged 18-28 years. Suggestions were made concerning pos­
sible future investigations of the relationship of EHF thres­
holds to the use of oral contraceptives.
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CHAPTER 1
INTRODUCTION
In recent years there has been a growing interest in the 
relationship between cardiovascular problems and the auditory 
system. More specifically, several authors have attempted to 
demonstrate elevated pure tone thresholds for subjects who suffer 
from cardiovascular disorders. Researchers using Extra-High 
Frequency (EHF) pure tone testing have had some success in demon­
strating such a relationship. The EHF frequencies typically used 
in these studies include lOK, 12K, 14K, 16K, and 18K Hertz.
Rosen and Olin (1965) hypothesized that elevated thresholds for 
these frequencies may reflect a process of vascular pathology that 
may eventually lead to arteriosclerosis and coronary disease.
The use of EHF pure tone testing may therefore be valuable in 
the early detection of cardiovascular disorders.
There are several factors in modern day life that contri­
bute to the development of cardiovascular disease. Included among 
these factors are tension, diet, lack of exercise, drug usage, 
etc. One possible factor that has received a great deal of study 
in recent years is the use of oral contraceptives. The literature 
concerning the effects of oral contraceptives on the cardiovas­
cular system is in many cases contradictory and inconclusive.
There are, however, several studies that demonstrate blood chem­
istry changes associated with cardiovascular disease in users of 
oral contraceptives. If such changes are produced by oral con­
traceptives, they may be manifested by elevated thresholds for 
the EHF frequencies.
Review of the Literature 
Vascular Anatomy of the Cochlea
In order to understand how cardiovascular disorders might 
affect the auditory system, it is necessary to have at least a 
basic knowledge of the vascular anatomy and physiology of the 
inner ear.
Fisch (Knight, 1970) discussed the auditory system in terms 
of its vulnerability to vascular changes. He described the com­
plex vascular arrangement of the inner ear as an indication of 
high metabolic activity in the auditory system. Fisch pointed 
out that systems of high metabolic activity are susceptible to even 
minor vascular changes. The author stated that the basal end of 
the cochlea is the area of highest inner ear metabolic activity and 
is therefore the portion most susceptible to vascular interruption. 
Finally, he stated that the blood flow through the extremely small 
arteries of the inner ear is more easily blocked or impaired than 
in larger vessels found in other systems of the body.
Axelsson (1968) provided an excellent description of the 
vascular anatomy of the human cochlea (see Figures 1 and 2).
FIGURE I
SCHEMATIC DIAGRAM OF THE ARTERIAL SYSTEM 
SERVING THE HUMAN COCHLEA^
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Redrawn from Axelsson, 1968.
FIGURE 2
SCHEMATIC DIAGRAM OF A TRANSVERSE SECTICW 
OF THE GUINEA PIG SPIRAL LAMINA^
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Redrawn from Axelsson, 1968.
The only direct source of blood supply for the inner ear is the 
internal auditory artery. The derivation of the internal audi­
tory artery is as follows: Vertebral Artery ------ *■ Basilar Artery
------Anterior-Inferior Cerebellar Artery ------ *■ Internal Auditory
Artery. As the internal auditory artery enters the cochlea, it 
divides into the anterior vestibular artery and the common coch­
lear artery. The common cochlear artery further divides into the 
vestibulocochlear artery and the cochlear artery. The vesti­
bulocochlear artery also branches into the vestibular and coch­
lear divisions. The vestibular branch supplies the basal end of the 
cochlea, while the cochlear branch supplies the middle and 
apical turns (Axelsson, 1968).
Several authors have stated that the susceptibility of the 
auditory system to even minor vascular changes is due to the fact 
that the cochlear arterioles are end arteries of only a single 
vessel (the internal auditory artery). Hallberg (1975) stated 
that these end arteries may be among the first to demonstrate 
early symptoms of atherosclerosis. Fowler (1959) pointed out 
that the arterioles of the Organ of Corti are terminal, and are 
therefore particularly susceptible to agglutination and clotting. 
Polus (1972) stated that since the inner ear is dependent on 
only one artery for its blood supply, any change, spasm, embolism, 
or thrombosis that may inhibit the function of this artery may 
also produce changes in the cochlea. Johnsson and Hawkins (1972)
suggested that a decrease in blood flow through the internal 
auditory artery can lead to anoxia and eventually to degeneration 
of the walls of those vessels that are supplied by it.
While there is general agreement in the literature concern­
ing the anatomical vulnerability of the auditory system to vascular 
changes, there is some disagreement as to whether the vascular 
anatomy of the cochlea creates a particular susceptibility of 
the basal end of the cochlea. Axelsson (1968) found the following 
two characteristics of the auditory vascular system in 60 cada­
vers: (1) the breadth of the stria vascularis decreased progres­
sively from basal to apical end; (2) there was a marked reduction 
of the number of arterio-venous anastomoses external to the 
stria vascularis in going from the basal to the apical end.
Axelsson suggested that the reduced number of anastomoses at the 
apical end of the cochlea allows for fewer possibilities for 
adjustment in the event of circulation changes. The basal end, 
with its greater number of anastomoses, should have more available 
pathways for shunting blood around portions of the capillary net­
work that may be damaged. The author's conclusion is that the vas­
cular anatomy of the cochlea does not appear to create a higher 
vulnerability for the basal end to vascular disorders as compared 
to the apical end.
Falbe-Hansen and Thomsen (1963), on the other hand, suggested 
that the vascular anatomy of the basal turn of the cochlea does
indeed make it particularly susceptible to circulatory defects.
They stated that the degree of development and complexity of the 
stria vascularis at the basal end may indicate that this region 
has the highest oxygen requirements. Thus any condition that 
reduces the oxygen delivery to the cochlea, such as partial or 
total blockage of the internal auditory artery or its branches, 
may produce the greatest damage at the basal end.
Other authors have suggested that the blood supply of the 
stria vascularis is not the crucial source of nutrients for main­
taining the inner ear hair cells. Lawrence (1966) stated that 
there are three capillary areas around the scala media that may 
serve to provide nutrients for the Organ of Corti: (1) stria
vascularis; (2) spiral prominence; (3) vas spirale. His study 
with 15 guinea pigs indicated that occlusion of the vas spirale 
resulted in a loss of cochlear hair cells, even when the stria 
vascularis and spiral prominence capillaries were intact. On 
the other hand, occlusion of only the stria vascularis network 
did not result in hair cell degeneration. Lawrence (1970) suggested 
that the vas spirale is responsible for nourishing the Organ of 
Corti, while the stria vascularis maintains the electrolytic 
balance within the endolymph.
Kirikae et al. (1969) provided a detailed description of 
the spiral lamina vascular system as found in 18 human temporal 
bone sections. The vas spirale is a looping capillary vessel that
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lies below the tunnel of Corti. The length of the loops vary from 
turn to turn, and the apical end of this vessel has more branching 
and anastomoses than the basal end. The authors stated that the 
capillary density of the 500 Hz area of the vas spirale is 1.5 
times greater than the capillary density of the 8K Hz area.
Kirikae et al. (1969) also described a second spiral vessel 
system that runs along the inner hair cells of the cochlea.
This vessel is well separated from the vas spirale at the basal 
end, but lies near the vas spirale at the apical end. This situa­
tion also favors the apical end in the event of circulatory 
disturbances; if the vas spirale fails to function due to vascular 
occlusion, the other spiral vessel can help compensate for the 
resulting loss of blood supply to the cells of the apical end to 
a much greater degree than those at the basal end.
Johnsson and Hawkins (1972) also described the outer spiral 
vessel as having fewer radiating capillaries as tributaries in the 
basal turn than in the middle and apical turns. If the vas 
spirale is indeed the source of nutrients for the Organ of Corti, 
the fewer capillaries and anastomoses at the basal end makes that 
portion of the cochlea more susceptible to damage from vascular 
pathology than the apical end.
The Relationship of Hearing Loss and Cardiovascular Disorders
Vascular pathology has been suggested as the cause of 
several forms of auditory pathology, including Meniere's disease
(Davis and Silverman, 1970), noise induced hearing loss (Hawkins, 
1971), drug ototoxicity (Lawrence, 1970), presbycusis (Fowler, 1959; 
Johnsson and Hawkins, 1972a, 1972b), and sudden deafness (Hallberg, 
1957; Altshuler and Welsh, 1966; Jaffe, 1967, 1968, 1970; Polus, 
1972; and Saunders, 1972).
Still another area of investigation is the relationship of 
hearing loss with cardiovascular disease and/or the physiological 
conditions associated with it. Certain studies have not succeeded 
in demonstrating such a relationship. Hopkinson and Lindberg 
(1971) obtained pure tone thresholds for the frequencies 250-8K 
Hz on four subjects suffering from hypertension. The thresholds 
obtained were not found to be significantly elevated, although 
the small number of subjects used reduced the power of this study. 
Hansen (1968) studied 342 hypertensive patients over 45 years of 
age. After eliminating those subjects with a history of noise 
exposure, the author found no significant differences between the 
pure tone thresholds of patients with normal blood pressure, 
slightly elevated blood pressure, and significantly elevated blood 
pressure.
Ismail et al. (1973) investigated the pure tone thresholds 
of 64 subjects aged 23-62 years. The experimental group consisted 
of 54 subjects who participated in an exercise program three times/ 
week for eight months. The control group consisted of ten subjects 
who did not participate in the exercise program. The exercise 
program produced physiological conditions that are not conducive
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to cardiovascular disease, such as a lowered resting heart rate, 
increased maximal oxygen intake, lowered submaximal heart rate, 
etc. Pure tone thresholds for the frequencies 2K, 4K, 6K, 8K, lOK, 
12K, and 14K Hz were obtained on all subjects before and after 
the exercise program was instituted. The authors found no sig­
nificant differences in thresholds between the experimental and 
control group for any of the frequencies tested. It should be 
noted that the exercise program did not reduce all the factors 
commonly associated with cardiovascular disease, such as serum 
cholesterol and glucose levels. Another important consideration 
is that most of the subjects did not demonstrate abnormal car­
diovascular conditions before the exercise program was initiated; 
it may be that the auditory system is affected only by abnormal 
physiological conditions associated with cardiovascular disease.
Drettner et al. (1975) investigated the relationship of pure 
tone thresholds with several different factors that may be present 
with cardiovascular disorders. The factors studied included 
systolic blood pressure, diastolic blood pressure, heart rate, 
serum cholesterol, serum triglycerides, uric acid, hematocrit, 
glucose tolerance, smoking habits, and noise exposure. The sub­
jects consisted of 762 men 50 years of age, all of whom demon­
strated at least one of the factors above. Pure tone thresholds 
were obtained bilaterally for the frequencies 500, IK, 2K, 3K, 4K, 
and 6K Hz. The authors found no significant correlations be-
11
tween hearing loss and cardiovascular risk factors, with the 
exception of smoking habits. It was discovered that those sub­
jects who had smoked for 10 years or more and who were currently 
smoking more than 10 cigarettes/day had poorer pure tone thresholds 
for the right ear than the subjects who did not smoke. The authors 
could not account for this selection difference for the right ear 
only.
While the studies cited above failed to demonstrate a rela­
tionship between hearing loss and physiological conditions character­
istic of cardiovascular disease, the current literature contains a 
number of studies that suggest such a relationship. Hopkinson 
and Lindberg (1971) found mild high frequency sensorineural hearing 
losses for the frequencies 250-8K Hz in six patients suffering 
from atherosclerosis. The authors admitted, however, that these 
hearing losses could be the result of other factors such as en­
vironmental noise or presbycusis.
Jaffe (1970) conducted a five year study involving 40 patients 
who suffered from sudden hearing loss. He found that 11 of the 
40 patients had demonstrated a pathological acceleration of blood 
coagulation after the sudden onset of hearing loss. Histologic 
investigation of one of these subjects who had died revealed intra- 
vascular clots in vessels of the spiral ligament and stria vascu­
laris.
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Rosen (1962) conducted a study of 541 members of the 
primitive Mabaan tribe in the Sudan. The subjects ranged in age from
19-90+ years, and pure tone thresholds were obtained for each sub­
ject for the frequencies 500-6K Hz. The results indicated that 
unlike modern Western society, the Mabaans did not acquire poorer 
pure tone thresholds for the high frequencies with aging. Rosen 
noted that this population is virtually free from high blood pressure, 
coronary thrombosis, ulcers, and other pathological conditions 
that frequently occur with aging in our own culture. Rosen con­
cluded that high blood pressure and atherosclerosis of small blood 
vessels of the inner ear may contribute at least in part to the 
progressive hearing loss characteristic of presbycusis. He does 
admit, however, that the superior hearing acuity of the Mabaans 
as compared to our own society may be attributable to other fac­
tors such as climate, racial differences, genetic factors, or the 
relatively noise free environment of the Mabaan tribe.
Rosen et al. (1964) continued their study of this tribe 
by obtaining pure tone thresholds for the frequencies 12K-24K Hz 
on at least 100 subjects in each decade between the ages of 10-70 
years. The authors conducted the same testing on at least 100 
subjects in every decade between 10-70 years in the cities of New 
York, Düsseldorf, and Cairo. The results indicated superior 
hearing for these frequencies among the Mabaan tribe as compared 
to the subjects found in the three cities. This superiority was 
evident for all age decades, but particularly for the age decades
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30-39 and older. The authors suggest that the lack of hypertension, 
atherosclerosis, or noise, and other environmental and genetic 
factors present in this tribe may all be factors related to their 
superior hearing acuity.
Rosen et al. (1970b) conducted another epidemiological 
study in the U.S.S.R., where they compared the pure tone thresholds 
of subjects from two different locations that have characteristically 
different diet habits. The two groups of subjects were divided 
as follows: (1) 235 clerical and factory workers aged 40-59 years
from Moscow, where the diet is characterized by high levels of 
saturated fats and carbohydrates, and the incidence of athero­
sclerosis and coronary heart disease is also high; (2) 188 clerical 
and factory workers aged 40-59 years from the Georgian Soviet 
Republic, where the diet typically is low in saturated fats and 
the incidence of coronary heart disease is also low. The authors 
hypothesized that a diet containing high levels of saturated fat 
disturbs blood lipid balance and may accelerate the development of 
atherosclerosis. This in turn may lead to occlusion of the 
tiny cochlear blood vessels, resulting in elevated pure tone 
thresholds.
The results indicated significantly better hearing for 
the Georgian subjects, and at 4K Hz the Georgian factory workers had 
better pure tone thresholds than the Moscow clerical workers.
The authors suggested that this finding indicates that the dif-
14
ferences in thresholds are primarily due to diet factors and not 
to the amount of noise exposure.
The three studies by Rosen et al. cited above would be more 
conclusive if the authors had actually demonstrated abnormal blood 
lipid levels for their subjects that exhibited elevated pure tone 
thresholds. Although the diets maintained by these subjects are 
characterized by high levels of saturated fats, there is no evidence 
presented that demonstrated pathological vascular changes such as 
elevated blood lipids. Thus it is difficult to determine if the 
elevated thresholds are really due to the differences in diet 
between the two groups.
In an attempt to demonstrate more conclusively the rela­
tionship of elevated pure tone thresholds and high fat diets,
Rosen and Olin (1965) conducted a study of patients in two mental 
institutions in Finland. The typical Finnish diet is high in 
saturated fats, and the country has one of the highest incidence 
rates in the world for coronary disease. The subjects for this 
study consisted of two groups from each hospital as follows: (1)
Experimental hospital— one group of 39 subjects aged 40-49 years, and 
another group of 97 subjects aged 50-59 years; (2) Control hospital—  
one group of 37 subjects aged 40-49 years, and another group of 
106 subjects aged 50-59 years. The experimental groups were 
maintained on a diet in which all milk fat was replaced by soybean 
oil, while the control groups maintained the typical Finnish diet. 
These dietary conditions were controlled for a period of five years.
15
resulting in decreases of mean serum cholesterol levels and blood 
coagulability for both experimental groups. Pure tone thresholds 
were obtained from all subjects for the frequencies 500-4K Hz and 
12K-24K Hz. The results indicated that the patients from the 
experimental hospital had better pure tone thresholds for all 
frequencies; for the frequencies 500-4K Hz and 12K-24K Hz the 
thresholds of the experimental patients aged 50-59 years were as 
good as, or better than, the thresholds of the control subjects 
aged 40-49 years. The frequency of response to the frequencies 
12K-24K Hz was higher for both experimental groups as compared 
to the corresponding age groups in the control hospital. The 
authors concluded that the differences in hearing thresholds may 
parallel the differences in saturated fat content of the diets 
employed. A major flaw in this study, however, is the absence of 
pure tone thresholds for the subjects before the experimental diet 
was introduced; it is possible that the experimental groups were 
superior to the control groups in hearing acuity even before the 
change in diet began.
Rosen et al. (1970a) continued their study of these sub­
jects by reversing the diets employed for a period of 3-1/2 years. 
Hospital N, originally on the soybean oil diet, returned to the 
typical Finnish diet, while Hospital K, originally on the typical 
Finnish diet, was now placed on the soybean oil diet. After the 
3-1/2 year period, the subjects from Hospital K had mean serum 
cholesterol levels 35-40 mg/100 ml lower than the serum cholesterol
16
levels of subjects from Hospital N, The authors were able to 
conduct audiometric testing on 90 of the original subjects from 
Hospital N and 75 of the original subjects from Hospital K.
The results in comparison to those obtained in the 1966 study in­
dicated that the thresholds at 500-6K Hz for the age group aged 
40-49 years were elevated for Hospital N, while the thresholds 
for the same age group in Hospital K demonstrated improvement. In 
neither case, however, were these changes in threshold statis­
tically significant. The subjects of Hospital N aged 50-59 years 
demonstrated significant elevation of thresholds for the fre­
quencies IK, 2K, and 4K Hz, while the subjects of the same age 
from Hospital K demonstrated significant improvements in thresholds 
for the frequencies 500 and 2K Hz.
The results from the EHF (12K-24K Hz) testing of the two 
groups aged 40-49 years in comparison to the 1964 results indicated 
a significant elevation of thresholds for 12K Hz and a drop in the 
frequency of response for the other Extra-High frequencies in 
subjects from Hospital N, while the thresholds in subjects from 
Hospital K demonstrated significant improvement at 12K Hz, with 
no change in frequency of response for the other Extra-High 
frequencies. There were no significant changes in thresholds 
for these frequencies in either of the 50-59 year groups, as the 
frequency of response for Extra-High frequencies by these groups 
was very low.
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Based on the results of their study of the two mental in­
stitutions, Rosen and Olin (1965) hypothesized that a young popula­
tion from an area with a high incidence of coronary disease should 
have poorer pure tone thresholds for the frequencies 12K-2AK Hz 
than a similar aged population from an area with a low incidence 
of coronary disease. To test this hypothesis, the authors con­
ducted a study of 42 East Finns aged 19-29, and a similar aged 
group of 68 Yugoslavs. As noted previously, the Finns are noted 
for having a high mean serum cholesterol level (297 mg/lOOml) 
and incidence of coronary heart disease; the Yugoslavs' on the 
other hand, have a much lower mean serum cholesterol level (183mg/ 
100ml) and one of the lowest incidence rates of coronary heart
disease in all of Europe. The results indicated that the Yugo­
slavs had significantly superior hearing for the frequencies 
14K and 16K Hz, particularly when comparing those subjects aged
20-29 years. The authors suggested that these differences may be 
a reflection of the initial stages of a developing vascular path­
ology. As in the previous studies cited, it is difficult to de­
termine if the differences in thresholds are truly a reflection
of differences in dietary habits or if they are due to some other 
factor(s).
Some authors have conducted studies that relate hearing loss 
to clinically diagnosed blood chemistry symptoms that are often 
associated with cardiovascular disease. Spencer (1973) performed
18
blood analyses on 300 subjects diagnosed as having inner ear 
disease. He defined inner ear disease as including hearing 
loss, tinnitus, and occasional vertigo. Of these 300 subjects, 
42.33% had clearly defined hyperlipoproteinemia (HLP), and another 
8.66% were diagnosed as having borderline HLP. Spencer defined 
hyperlipoproteinemia as including any of the following: elevated
plasma cholesterol levels; elevated serum lipoproteins; and ele­
vated serum triglycerides. The author pointed out that the in­
cidence of HLP in the normal population is 15-20%, while the in­
cidence for his experimental subjects is 51%. He concluded that 
hearing loss may be associated with elevated levels of serum 
cholesterol, triglycerides, and/or other blood components. He 
also noted that HLP has been associated with an increased risk of 
coronary heart disease, and he stated that hearing loss may occur 
with the early development of such disorders.
Cunningham and Goetzinger (1974) conducted a study to deter­
mine if Extra-High Frequency (EHF) thresholds can serve as pre­
dictive measures of hyperlipidemia and the development of early 
atherosclerosis. The authors stated that although blood tests can 
identify hyperlipidemia, they do not provide objective evidence of 
ischemic changes. EHF thresholds may be one way of demonstrating 
such changes.
The study involved 20 hyperlipidémie subjects (serum 
cholesterol > 350mg/100ml and triglycerides > 140mg/100ml) and 20
19
control subjects. All subjects were aged 20-50 years, had no history 
of noise exposure, were otologically normal, and passed a pure tone 
screening test of 20dB for IK and 2K Hz, and 35dB for 4K and 6K Hz. 
The results indicated modest, but significant differences in pure 
tone thresholds for the frequencies 10K-18K Hz. The differences 
were particularly evident for 14K Hz, and the thresholds for the 
right ear were more discriminating between the two groups than 
left ear thresholds. The authors concluded that EHF hearing acuity 
may act as a monitor of the atherosclerotic process as manifested 
in small arteries.
Podoshin et al. (1975) obtained pure tone audiograms for the 
frequencies 250-8K Hz on 59 subjects aged 41-59 years who had 
suffered myocardial infarction within the three years prior to the 
study. The control group consisted of 29 subjects of normal health 
who were matched with the experimental group for age. The authors 
controlled for those factors that could affect hearing acuity, 
such as family history of hearing loss, noise exposure, and drug 
usage. Normal hearing was defined as pure tone thresholds of 30dB 
or better for all frequencies tested. The results indicated that 
59.6% of the control subjects had normal hearing, while only 42.3% 
of the experimental subjects met the normal hearing criteria.
The authors also found that those subjects with blood sugar levels 
above 120mg/100ml had elevated pure tone thresholds compared to 
those subjects with normal blood sugar levels. The authors con­
cluded from this data that the hearing loss frequently seen in the
20
diabetic patient may be a manifestation of an atherosclerotic 
process.
Although the experimental designs of several of the studies 
cited above demonstrate certain weaknesses, there appears to be 
adequate evidence that the auditory system does reflect certain 
physiological symptoms often associated with cardiovascular 
changes.
Physiological Symptoms of Cardiovascular Disease Associated With 
the Use of Oral Contraceptives
One factor that may contribute to the development of physio­
logical symptoms associated with cardiovascular disorders is the 
use of oral contraceptives, although the literature concerning 
the effects of oral contraceptives on the vascular system contains 
many contradictions. Ham and Rose (1969) stated that the contra­
dictory results found in various studies may be due to different 
techniques and experimental designs used to assess the effects of 
oral contraceptives on the vascular system. There are, however, 
certain vascular effects of oral contraceptives that have been 
confirmed by several authors. Fletcher and Alkjaersig (Salhanick 
et al., 1969) suggested two alternative hypotheses relating the 
use of oral contraceptives to the development of symptoms of cardio­
vascular disease; (1) contraceptive agents induce in all, or a 
majority of users, some chemical alterations leading to cardio­
vascular disorders; or (2) oral contraceptives may unmask a small
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population predisposed to vascular changes characteristic of 
cardiovascular disorders.
Irey and Norris (1973) conducted a study designed to investi­
gate the possibility that the vascular system may be a target 
organ for lesions as a result of the use of oral contraceptives.
The authors studied the vasculature of various organs in 16 
cadavers. Seven of the subjects had been using oral contraceptives, 
five were pregnant, and four had recently given birth at the time 
of death. The control group consisted of female cadavers who had 
either died suddenly or who had been clinically diagnosed as having 
cardiovascular disease. The authors found thickening of the intimai 
(innermost) layer of the arteries of several organs in the experi­
mental cadavers, such that lumen size was reduced. This intimai 
thickening was judged to be greater for the experimental group than 
for the control group. It was concluded that although the vascular 
lesions could not be directly linked to the use of oral contra­
ceptives, the results indicated that contraceptives may contribute 
to the development of cardiovascular disease.
Researchers have attempted to correlate the use of oral 
contraceptives with various physiological conditions associated 
with cardiovascular disease. Brakman (Salhanick et al., 1969) 
conducted a study of 29 subjects using oral contraceptives, and 
he found increased fibrinolytic activity in those subjects as 
compared to control subjects. The fibrinolytic enzyme system
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dissolves small deposits of blood clotting elements in blood 
vessels; increased levels of these clotting elements produce in­
creased activity of the fibrinolytic enzyme system. Thus it was 
concluded that oral contraceptives may increase the level of blood 
clotting elements.
Daniel et al. (Boffa et al., 1973) found that women using 
oral contraceptives have an elevated level of Factor IX, a clotting 
factor found in the blood. Ygge et al. (1969) conducted blood 
analyses on 15 women who had used oral contraceptives for a 
period of one year. The authors found significant increases in 
plasminogen, number of blood platelets, and antifibrinolytic activity. 
Peterson et al. (Boffa et al., 1973) conducted a study of 33 women 
aged 17-44 years who had taken oral contraceptives for periods 
ranging from 2-48 months. The results of blood analyses indicated 
depressed levels of antithrombin III and elevated levels of plas­
minogen when compared to control subjects; both of these conditions 
are conducive to an increased risk of vascular thrombosis.
Bolton et al. (1968) found abnormal blood platelet sensi­
tivity to adenosine diphosphate (ADP) in 11 women using oral contra­
ceptives as compared to a control group. The authors noted that 
this pattern of abnormal blood platelet sensitivity to ADP is similar 
to the pattern exhibited by patients with arterial occlusive dis­
ease. Aronson et al. (1971) reported a study in which eight of 
their 47 experimental subjects using oral contraceptives demonstrated
23
elevated blood viscosity as compared to 12 control subjects. Fisch 
and Freedman (1975) reported an increased rate of fibrin formation 
and increased blood clot firmness in women using oral contra­
ceptives as compared to control subjects.
One of the blood component conditions that has been consis­
tently associated with the use of oral contraceptives is an elevated 
level of blood lipids, de Alvarez et al., (1973) defined blood 
lipids as including fatty acids, neutral fats, phospho-lipids, 
cholesterol, and vitamins A, D, E, and K. Stokes and Wynn (1971) 
stated that most forms of hyperlipidemia are associated with the 
premature development of occlusive vascular disease, de Alvarez 
et al. (1973) offered three experimental findings that suggest that 
lipids might play a role in vascular pathology: (1) esterified
cholesterol is known to accumulate in fibrous plaques in blood 
vessels; (2) atherosclerosis can be experimentally induced in animals 
by maintaining them on a high cholesterol diet; (3) according to the 
authors, a study conducted in Framingham and Osle related elevated 
lipid levels in apparently healthy people to subsequent coronary 
heart disease.
Wynn, Doar, and Mills (1966) studied the blood lipid levels 
of 102 women using oral contraceptives and compared them to the 
blood lipid levels of 75 control subjects. The contraceptives used 
included Ovulen, Metrulen, Conovoid, and Anovlar. Both the exper­
imental and the control groups were divided into one group aged
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20-29 years and another group aged 30-39 years. Significant 
differences for serum cholesterol levels were found between the 
experimental and control groups aged 20-29 years only. The serum 
triglyceride levels were significantly higher for both age cate­
gories in the experimental group as compared to the control group;
31% of the experimental group had serum triglyceride levels above 
131mg/100ml, the highest level found for any of the control subjects.
The authors noted that there are both retrospective and 
prospective studies that associate elevated serum lipid levels with 
the development of atherosclerosis. They therefore suggested that 
the use of oral contraceptives may be a contributing factor to 
the development of cardiovascular disease. A weakness of this 
study is that blood lipid levels were not assessed before the use 
of oral contraceptives began, making it difficult to directly re­
late elevated blood lipids to the use of oral contraceptives.
Brody et al. (1968) studied the effects of oral contra­
ceptives on blood lipid levels of nine women taking Anovlar, nine 
women taking Ovulen, and six women using Volidan. Blood lipid 
levels were assessed before administration of the medication, and 
again after the first, third, sixth, and twelfth months of use.
The results indicated no significant changes in serum cholesterol 
levels, but triglyceride levels were significantly elevated for 
those subjects using Ovulen or Volidan. The authors noted that 
different types and amounts of estrogen and progesterone compounds
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have varying effects on blood lipids. Their results indicated that 
oral contraceptives with predominantly estrogenic activity (Ovulen 
and Volidan) elevate blood lipids, while those contraceptives with 
predominantly progesterogenic activity (Anovlar) produce the 
opposite results. The authors concluded that the effects of various 
oral contraceptives on blood lipids are dependent on the estrogen 
and progesterone dosage levels relative to each other.
Sachs et al. (1969) investigated the blood lipid levels of 
19 women aged 17-42 years who were using Ovulen. Blood analyses 
were performed before the subjects began using the oral contra­
ceptive and again at several intervals during the following 18 
months. The results indicated a progressive elevation of tri­
glycerides in 16 subjects, so that at the end of the 18 months the 
mean triglyceride level was 40mg/100ml above the mean level obtained 
before the medication was taken. This elevation did not, however, 
exceed the normal limits of ISOmg/lOOml as defined by the authors. 
Phospholipids were also elevated in 12 subjects to a level of 
267-276mg/10Qml, and serum cholesterol levels were increased 
slightly but not to a significant degree.
Wynn et al. (1969) studied the blood lipid levels by using 
two different approaches: (A) 116 women were tested before and
during the use of oral contraceptives; (B) 48 women were tested dur­
ing and after discontinuation of the use of oral contraceptives.
The majority of subjects were using either Ovulen or Gynovular.
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The mean duration of use of contraceptives for Group B was 25.4 
months. The authors defined the upper limit of normal triglyceride 
levels as 131mg/100ml. The results indicated that 15 Group A 
subjects and 21 Group B subjects demonstrated abnormally elevated 
triglyceride levels during the use of the medications. At least 
some elevation of serum triglycerides was found for 111 of 116 
subjects in Group A. The authors stated that while not all women 
developed elevated serum triglyceride levels above the normal 
limit, it is possible that even small increases in serum lipids 
may accelerate the development of atherosclerosis.
Ham and Rose (1969) investigated the response of lipopro­
tein lipase to heparin in 19 subjects aged 20-38 years who had 
taken oral contraceptives for at least six months. Eleven of the 
subjects were using Ovulen, three were using Anovlar, and the 
other five were each using a different medication. The control 
group consisted of 21 subjects aged 20-35 years. The results indi­
cated that the mean lipoprotein lipase activity was significantly 
lower in the experimental group as compared to the control group, 
with a mean reduction of 38%. The lipoprotein lipase activity of 
13 of the experimental subjects was lower than the lowest activity 
level found for any of the controls. The authors referred to a 
study by Garfinkel et al. that demonstrated a direct relationship of 
triglyceride absorption of adipose tissue to the lipoprotein lipase 
activity of that tissue. Thus the elevated blood lipids found by
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many researchers in users of oral contraceptives may be due to a 
reduced ability to clear the blood of excess triglycerides via 
the lipoprotein lipase activity.
Stokes and Wynn (1971) studied the serum lipid levels in 525 
women using estrogen-progesterone combination pills, 35 women 
using sequential pills, and 116 control subjects. The mean serum 
triglyceride levels for women using Ovulen or Volidan were 112 
mg/100ml and llSmg/lOOml respectively, while the mean serum 
triglyceride level for the control group was 68mg/100ml. Since 
Ovulen and Volidan contain the greatest concentrations of estro­
gen content of any of the medications used, the authors concluded 
that the estrogen content appears to determine the degree of ele­
vation of serum triglycerides in users of oral contraceptives.
The authors also noted that the elevated lipid levels found in 
users of oral contraceptives resembles the pattern found in patients 
diagnosed as having Type IV hyperlipoproteinemia. They further 
noted that several authors have associated that pattern type with 
an accelerated development of atherosclerosis.
Schenker et al. (1972) conducted a study of serum lipids of 
375 women aged 19-30 years who were using either combination or 
sequential oral contraceptives, and 66 control subjects. The dura­
tion of oral contraceptive use ranged from 3 to 37 months. The 
results indicated significantly higher triglyceride and total serum 
lipid levels in the experimental group as compared to the control 
group; the mean total serum lipid level for the control group was
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596mg/100ml, while the mean for the experimental group was 
722mg/100ml.
Spellacy et al. (1973) measured the serum lipid levels of 
245 women using oral contraceptives, 126 of whom were using Ovulen. 
The authors claimed to have two control sources available to them;
(1) the pretreatment serum lipid levels of the experimental group;
(2) 38 control subjects not using oral contraceptives. Serum 
lipid levels were measured six and twelve months after the use of 
the medications began. The results indicated significantly ele­
vated serum triglyceride levels for the high estrogen compound 
Ovulen as compared to the two control conditions. There were no 
significant differences in triglyceride levels between the six
and twelve month time periods. The authors suggested that elevated 
triglycerides in the extreme may contribute to acute vascular 
accidents.
Donde and Virkar (1975) analyzed the serum triglycerides, 
free fatty acids, phospholipids, and cholesterol in women aged 19-41 
years who were using estrogen-progesterone combination pills. The 
authors excluded from their study those subjects who had a history 
of thrombophlebitis, diabetes, hypertension, or kidney and heart 
disease. The results indicated significantly elevated serum levels 
of all four components tested for, although none of the components 
were elevated beyond normal limits. The greatest elevation of serum 
triglycerides was demonstrated by those subjects who had been using
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Ovral for 25-36 months.
Conclusions concerning the effects of oral contraceptives on 
the vascular system are difficult to make. The literature con­
cerning the effects of oral contraceptives on individual blood 
components is plagued by a lack of uniformity in experimental 
design, techniques of assessment, and even criteria for normality. 
There does seem to be general agreement among various studies that 
the use of oral contraceptives, particularly the estrogen-progesterone 
combination type, may produce elevated blood serum lipids.
The research concerning the vascular effects of oral contra­
ceptives offers several possible mechanisms whereby the auditory 
system might be affected. This is especially true for the effect 
of elevated blood lipids, particularly in view of the findings of 
Rosen (1964, 1965, 1970a), Spencer (1973), and Cunningham and 
Goetzinger (1974). The possible effects of oral contraceptives on 
hearing acuity has been recognized by at least two authors. Spencer 
(1973) cited Levy and Stone in stating that oral contraceptives 
may be a secondary cause in the production of a Type IV hyperlipopro­
teinemia. Based on the results of his study cited previously, he 
concluded that an audiological examination may aid in the early 
detection of hyperlipoproteinemia in patients who are high risks for 
developing atherosclerosis. Shulman (1974) discussed his clinical 
impressions of the relationships of hearing loss, tinnitus, vertigo, 
alone or in combination, to the use of oral contraceptives. He 
suggested that oral contraceptives be considered as a possible
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etlologlc factor In the diagnosis of hearing loss.
Statement of Purpose
The purpose of this study was to Investigate the relation­
ship of the use of oral contraceptives and Extra-High Frequency 
(EHF) thresholds In women aged 18-28 years. More specifically, the 
experiment was designed to test the following hypotheses:
Ho^: Women using the estrogen-progesterone combination
oral contraceptives will demonstrate elevated EHF (10-18K Hz) 
pure tone thresholds as compared to a control group of women who 
have never used oral contraceptives.
HOg: The elevation of EHF pure tone thresholds will be
greater as the duration of use of the medication Increases.
CHAPTER II
PROCEDURE
Subi ects
A total of 42 subjects aged 18-28 years were used in this 
study. The subjects were divided into three groups as follows:
(1) Group A consisted of 14 subjects who have been using oral con­
traceptives continuously for the last 4 years or more; (2) Group 
B consisted of 14 subjects who have been using oral contraceptives 
continuously for the last 1-3 years; (3) Group C consisted of 14 
subjects who have never used oral contraceptives.
The subjects were restricted in age to the years 18-28 in 
order to minimize the possible effects of beginning presbycusis;
Rosen (1965) and Drettner et al. (1975) stated that the onset of 
presbycusis can occur as early as the third decade of life.
Smoking is another factor for which subjects were controlled, Allison 
and Roth (1969) listed the following three effects of cigarette 
smoking on the vascular system as being generally accepted by 
researchers: (1) constriction of peripheral blood vessels; (2)
increased pulse rate; (3) increased systolic and diastolic blood 
pressure.
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Diehl (1969) and Constantinides (197L) discussed the presence 
of carbon monoxide in cigarette smoke and the resulting reduced 
oxygen-carrying capacity of the blood. Diehl (1969) stated that 
in the average smoker carbon monoxide inactivates 2-6% of the 
hemoglobin available, and in the heavy smoker up to 8% is inactivated. 
The carbon monoxide has a greater affinity for hemoglobin than does 
oxygen, and therefore the blood has a reduced capacity for carrying 
oxygen to the cells of the body. When one considers the discussion 
by Fisch (1970) of the auditory system as one of high metabolic 
activity and oxygen consumption, particularly at the basal end, 
it appears that cigarette smoking could be a contributing factor 
in elevated EHF thresholds. This factor was controlled for by 
eliminating those subjects who could be defined as "regular smokers." 
A "regular smoker" was operationally defined as a person who smokes 
more than 20 cigarettes/week.
All subjects were also required to meet the following cri­
teria: (1) normal middle ear functioning bilaterally as demon­
strated by impedance audiometry; (2) bilateral pure tone thresholds 
of lOdB or better for 2K and 4K Hz, and 15dB or better for 6K Hz;
(3) no reported history of noise exposure; (4) no reported problems 
with blood pressure; (5) no reported history of ototoxic drug 
usage; (6) no restrictive dietary programs, such as low cholesterol 
or low sugar diets; and (7) no personal history of diabetes. All 
subjects for the 2 experimental groups and the control group were 
young women from the University of Montana and the community of
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Missoula who volunteered for the study after being informed of its 
purpose by the author directly or by volunteers representing him.
Instrumentation
All audiological testing was conducted in a single-walled 
Industrial Acoustics Company (lAC) sound-treated room at the 
University of Montana Speech and Hearing Clinic. Ambient noise 
measurements of the sound-treated room were conducted prior to 
the experimental testing of subjects, and the levels were found 
to be within acceptable limits in reference to ANSI 1969 standards. 
Tympanometry for the assessment of middle ear functioning was 
accomplished with an American Electromedics Acoustic Impedance 
Bridge. Pure tone testing for the frequencies 2K, 4K, and 6K Hz 
was carried out on a Grason-Stadler Bekesy Audiometer (Type E-800) 
with the frequencies delivered to the ear via TDH-39 earphones.
This testing served to establish normal hearing for the conventional 
audiometric frequencies and also provided a practice period for the 
patient in operating the Bekesy audiometer. Extra-High Frequency 
audiometry was conducted with a Grason-Stadler (Type E-800) Bekesy 
Audiometer, which utilizes a General Radio Beat Frequency Audio 
Generator (1304-B) as a signal source. The signal was routed to an 
Allison Variable Filter (AL-2B), and then to a McIntosh Power 
Amplifier (MG40). The Extra-High Frequencies were delivered to 
the ear via a pair of Koss Pro (4AA) stereophonic earphones.
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Periodic intensity calibration of the Grason-Stadler Bekesy 
Audiometer (E-800) for the conventional audiometric frequencies 
was carried out with a Bruel and Kjaer (B and K) Condensor Micro­
phone Cartridge (4131), combined with a B and K Artificial Ear (4152) 
connected to a B and K Sound Level Meter (2203). Calibration of 
the equipment for the Extra-High Frequencies involved the use of a 
B and K Artificial Ear (4152) utilizing a B and K Condensor Micro­
phone (4132), in combination with a B and K Audio Frequency Spectro-
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meter (2112). This equipment was also used to obtain a 1/3 Octave 
Band analysis of the signal output from the Koss Pro (4AA) earphones 
with input signals centering on the frequencies lOK, 12.5K, 16K, and 
20K Hz. The results obtained with each of the four input signals 
listed above indicated decreased output sound pressure levels of 
45-50 dB/octave for frequencies above and below the center frequency. 
The Koss Pro (4AA) earphones were therefore judged to be adequate 
transducers for the purposes of this study.
3It should be noted that the B & K Artificial Ear (4152) 
is designed to be used for calibration of supra-aural earphones 
and not for a circumaural earphone such as the Koss Pro (4AA) 
(Wilbur, 1972). The sound pressure levels for the Extra-High fre­
quencies obtained with this calibration system are therefore not 
necessarily the true sound pressure levels present at the patient * s 
eardrum. However, the calibration procedure used in this study was 
not intended to determine the exact sound pressure level at the 
eardrum but rather to verify that the earphone output remained con­
stant from one test session to the next. The calibration system 
described above was considered to be adequate for its intended 
purpose.
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Procedure
Case history information, impedance results, and pure tone 
test results for the conventional audiometric frequencies were 
obtained before EHF testing began. Because of differences in the 
shape and size of the external auditory meatus among subjects, ear­
phone placement for each EHF was achieved by a "best fit" method, 
whereby the subject varied the earphone position until a constant 
suprathreshold tone sounded the loudest. This "best fit" method 
was used by each subject for each ear at each of the 5 Extra-High 
Frequencies tested. Pulsed tone, fixed frequency Bekesy tracings 
were obtained for the frequencies lOK, 12K, 14K, 16K, and 18K Hz, 
bilaterally. The order of ear presentation was alternated for each 
successive subject in each of the three groups. The tracings for 
each frequency were carried out for one minute, and the midpoint 
of the upward and downward movement of the pen closest to the 45th 
second was recorded as the threshold for that frequency. This 
procedure was adopted in an attempt to replicate as closely as 
possible the procedure used in a previous study (Cunningham and 
Goetzinger, 19 74).
A mean EHF hearing threshold level for each ear at each of 
the five frequencies tested was calculated for each of the 3 sub­
ject groups. A Lindquist Type I, repeated measures analysis of 
variance was used to evaluate the test results for each of the 
five Extra-High Frequencies.
CHAPTER III
RESULTS
The two major hypotheses of this study were as follows:
Ho^: Women using the estrogen progesterone
combination oral contraceptives will 
demonstrate elevated EHF (10K-18K Hz) 
pure tone thresholds as compared to a 
control group of women who have never 
used oral contraceptives;
HOg: The elevation of EHF pure tone thresholds
will be greater as the duration of use of 
oral contraceptives increases.
The data used in this study consisted of pure tone thres­
holds for both ears of each subject for the frequencies lOK, 12K, 
14k , 16K, and 18K Hz. The mean and standard deviation for age 
for each of the three subject groups is listed in Table 1. The 
raw data used for the statistical analyses are presented in 
Appendix A. Table 2 presents the mean raw score and standard 
deviation for each group with frequency, ear tested, and duration 
of use of oral contraceptives considered. The results were 
analyzed using a Lindquist Type I "repeated measures" analysis of 
variance for each of the 5 Extra-High Frequencies tested. A summary 
of the analysis of variance for each of the five Extra-High Fre­
quencies tested is presented in Tables 3^-3^. Table 4 presents 
the results comparing the variance of each subject group with the 
variance of the other two subject groups for each ear at each of
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TABLE 1
GROUP MEANS AND STANDARD DEVIATIONS FOR AGE
GROUP Mean Standard Deviation
Group A (4+ years on 
oral contraceptives) 22.85 years 1.46
Group B (1-3 years on 
oral contraceptives) 22.79 years 2.33
Group C (0 years on 
oral contraceptives) 22.42 years 2.50
TABLE 2
MEAN AND STANDARD DEVIATIONS FOR EHF HEARING THRESHOLD (dB SPL) BY FREQUENCY, 
EAR TESTED, AND DURATION OF USE OF ORAL CONTRACEPTIVES
RIGHT EAR
0 years 1-3 years 4+ years Total (All Subjects)
F Mean S.D. Mean S.D. Mean S.D. Mean S.D.
lOK 29.57 5.04 27.14 5.18 30.50 9.49 29.07 7.04
12K 45.50 10.64 42.21 7.03 38.50 11.22 42.07 10.22
14K 47.00 10.77 40.36 12.12 43.07 11.38 43.48 11.74
16K 61.07 17.32 53.21 18.26 59.21 20.49 57.83 19.05
18K 82.29 13.68 76.50 17.74 79.93 15.06 79.57 15.78
LEFT EAR
0 years 1-3 years 4+ years Total (All Subjects)
F Mean S.D. Mean ■ S.D. Mean S.D. Mean S.D.
lOK 29.29 4.15 26.29 8.38 30.07 6.06 28.55 6.63
12K 41.86 9.75 39.64 12.10 40.64 16.11 40.71 12.97
14K 44.14 16.08 39.71 14.68 47.07 12.81 43.64 16.61
16K 61.57 20.89 58.00 21.06 61.79 19.24 60.45 28.79
18K 86.00 14.78 79.43 17.36 80.64 19.49 82.02 26.49
w00
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TABLE 3.A
SUMMARY OF ANALYSIS OF VARIANCE 
OF EHF THRESHOLDS AT lOK Hz
SOURCE Sums of Squares
Degrees of 
Freedom
Mean
Squares
F
Ratio P
TOTAL 3932.95 83
BETWEEN SUBJECTS 3057,95 41
Duration of use 194.67 2 97.33 1.33 NS
Error^ 2863.28 39 73.42
WITHIN SUBJECTS 875.00 42
Ear tested 5.76 1 5.76 <1.00 NS
Ear tested x duration 1.24 2 .62 <1.00 NS
Error 868.00 39 22.26w
F .05, df 2/39 = 3.24
F .03, df 1/39 = 4.09
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TABLE 3B
SUMMARY OF ANALYSIS OF VARIANCE 
OF EHF THRESHOLDS AT 12K Hz
SOURCE Sums of Squares
Degrees of 
Freedom
Mean
Squares
F
Ratio P
TOTAL 11470.00 83
BETWEEN SUBJECTS 4612.54 41
Duration of use 245.22 2 122.61 1.09 NS
Error^ 4367.32 39 111.98
WITHIN SUBJECTS 6857.46 42
Ear tested 38.68 1 38.68 <1.00 NS
Ear tested x duration 132.64 2 66.32 <1.00 NS
Error^ 6686.14 39 171.45
F .05, df 2/39 = 3.24
F .05, df 1/39 = 4.09
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TABLE
SUMMARY OF ANALYSIS OF VARIANCE 
OF EHF THRESHOLDS AT 14K Hz
SOURCE Sums of Squares
Degrees of 
Freedom
Mean
Squares
F
Ratio P
TOTAL 15122.70 83
BETWEEN SUBJECTS 11288.20 41
Duration of use 525.02 2 265.51 <1.00 NS
Error^^ 10763.18 39 275.98
WITHIN SUBJECTS 3834.50 42
Ear tested .58 1 .58 <1.00 NS
Ear tested x duration 171.46 2 85.73 <1.00 NS
Error 3662.46 39 93.91w
F .05, df 2/39 = 3.24
F .05, df 1/39 = 4.09
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TABLE 3p
SUMMARY OF ANALYSIS OF VARIANCE 
OF EHF THRESHOLDS AT 16K Hz
SOURCE Sums of Squares
Degrees of 
Freedom
Mean
Squares
F
Ratio P
TOTAL 32996.29 83
BETWEEN SUBJECTS 29959.29 41
Duration of use 534.50 2 267.25 <1.00 NS
Errorj^ 29424.79 39 754.48
WITHIN SUBJECTS 3037.00 42
Ear tested 144.05 1 144.05 1.99 NS
Ear tested x duration 64.31 2 32.16 <1.00 NS
Error 2828.64 39 72.53w
F .05, df 2/39 = 3.24
F .05, df 1/39 = 4.09
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TABLE 3_
£i
SUMMARY OF ANALYSIS OF VARIANCE 
OF EHF THRESHOLDS AT 18K Hz
SOURCE Sums of Squares
Degrees of 
Freedom
Mean
Squares
F
Ratio P
TOTAL 23507.56 83
BETWEEN SUBJECTS 20378.06 41
Duration of use 545.45 2 272.73 <1.00 NS
Error^^ 19832.61 39 508.53
WITHIN SUBJECTS 3129.50 42
Ear tested 126.29 1 126.29 1.66 NS
Ear tested x duration 33.89 2 16.95 <1.00 NS
Error 2969.32 39 76.14w
F .05, df 2/39 = 3.24
F .05, df 1/39 = 4.09
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TABLE 4
SUMMARY OF F-TESTS COMPARING GROUP VARIANCES 
BY EAR TESTED AND FREQUENCY
RIGHT EAR
Comparisons lOK 12K 14K 16K 18K
Group A with Group B 
Group A with Group C 
Group B with Group C
3.36
3.56
1.05
2.54
1.11
2.29
1.13
1.12
1.27
1.26
1.40
1.11
1.39
1.21
1.68
LEFT ]EAR
Comparisons lOK 12K 14K 16K 18K
Group A with Group B 
Group A with Group C 
Group B with Group C
1.91
2.13
4.08
1.77
2.73
1.54
1.31
1.58
1.20
1.20
1.18
1.02
1.26
1.74
1.38
F .05, df 13/13 = 2.58
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the five frequencies tested. A confidence level o f . 05 was used 
for all tests of significance.
The results of the analyses of variance indicate that the 
EHF pure tone thresholds of women using oral contraceptives were 
not significantly different from those of women who have never 
used oral contraceptives at any of the five frequencies tested.
The results also indicate that there were no significant differ­
ences between right and left ear thresholds for subjects at any 
of the five Extra-High Frequencies. Finally, the interaction of 
duration of use of oral contraceptives by ear tested was not 
statistically significant. The results of all F tests computed 
in Tables 3^-3^ were not statistically significant even at the 
.10 level of confidence.
The major factors under consideration in this study included: 
(1) duration of use of oral contraceptives (0 years, 1-3 years, and 
4+ years); and (2) right versus left ears. When a non-statistical 
comparison of the mean EHF hearing thresholds of the two groups 
of oral contraceptive users was made for each ear at each of the 
five frequencies tested, it was discovered that the group of sub­
jects who have used oral contraceptives for four or more years had 
higher mean hearing thresholds than the subjects who have used oral 
contraceptives for 1-3 years in nine out of the ten possible compari­
sons. However, when comparing the mean EHF thresholds of the sub­
jects using oral contraceptives with the control group for each ear 
at each frequency tested, no such consistent pattern emerges.
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The results of the 30 F-tests comparing the variance of 
each subject group with the variance of the other two subject 
groups for each ear at each of the five frequencies tested indicate 
that only 4 of the possible 30 F-ratios computed were statistically 
significant.
CHAPTER IV 
DISCUSSION
The purpose of this study was to investigate the possible 
effects of oral contraceptives on Extra-High Frequency (EHF) pure 
tone thresholds. The literature concerning the effects of oral 
contraceptives on the vascular system contains several studies 
which have demonstrated that blood serum lipids and certain blood 
clotting components are significantly elevated in women who use 
oral contraceptives. Other studies have demonstrated elevated EHF 
pure tone thresholds in subjects with clinically diagnosed ele­
vated blood lipids as compared to control groups (Rosen and Clin, 
1965; Rosen et al., 1970a; Cunningham and Goetzinger, 1974). This 
author therefore hypothesized that if significant blood chemistry 
changes such as elevated blood lipids and other clotting factors 
occur in women who use oral contraceptives, such changes may be 
manifested in elevated EHF thresholds as compared to the EHF 
thresholds of women who have never used oral contraceptives.
The results of this study indicate no significant differ­
ences in EHF pure tone thresholds between a group of women using 
oral contraceptives and a control group at any of the five EHFs 
tested. These findings are not in agreement with those reported
in previous investigations of EHF hearing acuity in subjects demon-
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strating elevated blood lipids (Rosen arid Olin, 1965; Rosen et al., 
1970; Cunningham and Goetzinger, 1974). However, there are several 
differences between this study and previous studies that alone, or 
in combination, may account for the differences in the results.
Some of the major differences between this study and those 
done previously involve the criteria used for subject selection.
For example, the subjects for this study were required to have 
bilateral pure tone thresholds of lOdB or better at 2K and 4K Hz, 
and 15dB or better at 6K Hz. In the Cunningham and Goetzinger 
(1974) study concerning the relationship of EHF hearing acuity 
and elevated blood lipids, subjects were required only to have 
bilateral pure tone thresholds of 20dB at IK and 2K Hz, and 35dB 
at 4K and 6K Hz. The conclusion of their study was that elevated 
EHF thresholds were significantly related to elevated blood lipid 
levels. However, the above criteria may have allowed for selection 
as subjects some people with minimal high frequency hearing loss 
due to factors such as heredity, illness, high fevers, etc. If 
such was the case, it would be difficult to determine whether the 
elevated EHF thresholds found in their experimental subjects were 
related to abnormally elevated blood lipids or to some other fac­
tor leading to high frequency hearing loss. The studies conducted 
by Rosen (1964, 1965, 1970a) reported no specific criteria for sub­
ject hearing acuity at the conventional audiometric frequencies, 
and they also did not appear to control their selection of subjects 
for factors that might contribute to EHF hearing loss.
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Another difference between this study and that conducted by 
Cunningham and Goetzinger (1974) is the criterion restricting the 
age of the subjects. The age criterion for this study required 
that subjects be between 18 and 28 years of age. The Cunningham 
and Goetzinger study, on the other hand, required only that sub­
jects be between 20 and 50 years of age. An age criterion of such 
wide range could allow for an age distribution between and within 
groups such that the differences found in EHF thresholds might be 
due to sampling error only. Rosen (1964) and Drettner et al (1975) 
stated that the onset of presbycusis can occur as early as the third 
decade of life. If such is the case, the age criterion of the 
Cunningham and Goetzinger (1974) study does not appear to be re­
strictive enough to eliminate presbycusis as a possible factor 
influencing their findings. Thus the elevated EHF thresholds 
found in the experimental group as compared to a control group may 
be due at least in part to possible age differences between experi­
mental and control subjects.
The differences in results between this study and those 
conducted by Rosen et al. (1964, 1965, 1970a) and Cunningham and 
Goetzinger (1974) may be due to the stricter control in subject 
selection for age and hearing acuity for conventional audiometric 
frequencies used in the current study. However, this study also 
differs from previous investigations using EHFs in terms of the 
method used for delivering the acoustic signal to the ear. The
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experimental procedure for this study involved the use of earphones 
for delivery of the EHFs to the ear. Earphone placement for each 
EHF was achieved by a "best fit" method, whereby the subject varied 
the earphone position until a constant suprathreshold EHF pure tone 
sounded the loudest. Every subject carried out this procedure on 
each ear for each of the five frequencies tested. The technique 
used for signal delivery to the ear in previous studies of EHFs 
involved the use of a probe tube that inserts into the ear canal 
in place of conventional earphones (Rosen et al., 1964; Vassalo 
et al., 1968). The probe tube assembly allows the experimenter 
to place the signal source at a relatively constant distance from 
the tympanic membrane for all subjects.
Some authors have suggested that the use of earphones for 
delivery of EHFs is unsatisfactory due to individual differences 
in ear canal size and shape and the cavity size interaction with 
the wavelength of the signals (Rosen et al., 1964). An attempt 
was made in this study to control for these individual differences 
by use of the "best fit" technique of earphone placement for each 
EHF as described previously. The results of 30 F-tests comparing 
the variance of each subject group with the variance of the other 
two subject groups for each ear at each of the five frequencies 
tested indicate that only four of the 30 F-ratios computed were 
statistically significant. Thus, in only a minor number of cases 
did the variance of one subject group differ significantly from 
the variances of either of the other two subject groups. These
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findings suggest that the use of earphones with a "best fit" method 
for placement is an appropriate technique for this study. Although 
the use of a probe tube assembly rather than earphones may have 
yielded more precise EHF thresholds, it does not appear to be a 
crucial factor in this study which compared results between matched 
control and experimental groups.
A nonstatistical observation of the mean thresholds of the 
three subject groups for each ear at each of the five frequencies 
tested provides an interesting finding in this study. Disregarding 
the control group, the group of subjects who have used oral con­
traceptives for the last four or more years demonstrated higher 
mean thresholds than the group of subjects who have used oral 
contraceptives for the last one to three years in nine out of the 
ten possible comparisons. The consistency of the higher mean 
EHF thresholds for the "long term" (4 or more years) oral contra­
ceptive users as compared to the "short term" (1-3 years) oral 
contraceptive users across frequencies and ears may be an indi­
cation of some effect of duration of oral contraceptive use on the 
auditory system. However, the mean EHF thresholds of the control 
group are higher than those of the "long term" oral contraceptive 
users in six out of ten possible comparisons, and are higher 
than those of the "short term" oral contraceptive users in all 
ten possible comparisons.
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The results of this study indicate that women who use oral 
contraceptives did not have significantly different EHF pure tone 
thresholds than women who have never used oral contraceptives.
These findings suggest that oral contraceptives do not elevate as a 
group the blood lipids and various other blood clotting elements 
sufficiently to affect the EHF hearing acuity.
Recommendations for Further Research
The results of this study indicate that women, as a group, 
who use oral contraceptives did not demonstrate significantly 
elevated EHF pure tone thresholds as compared to the EHF thresholds 
of women who have never used oral contraceptives. However, further 
investigation of the relationship of EHF thresholds to the use of 
oral contraceptives utilizing different experimental procedures 
may be productive. Listed below are some suggestions for further 
investigation of this subject.
1. It may be useful to investigate the EHF thresholds of a 
select group of subjects who demonstrate various side effects from 
use of oral contraceptives. Fletcher and Alkjaersig (Salhanick et 
al., 1969) hypothesized that oral contraceptives may induce cer­
tain blood chemistry changes in a minority of users who may be 
predisposed to such alterations. Perhaps those individuals who 
suffer various side effects from oral contraceptives are also sus­
ceptible to certain blood chemistry changes which in turn may affect 
EHF hearing acuity.
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2. If significantly elevated EHF thresholds are found in a 
select group of subjects such as those discussed above, it might
be useful to investigate whether or not the factor of smoking has 
any additional effect on EHF thresholds. A study conducted by 
Drettner et al. (1975) indicates that there may be a relationship 
between smoking and hearing acuity. One could design a study in 
which the EHF thresholds of women who demonstrate a number of side 
effects from the use of oral contraceptives and who also smoke are 
compared with the EHF thresholds of another select group of oral 
contraceptive users who do not smoke.
3. If significantly elevated EHF thresholds as compared to 
those of a control group are found in a select subject group such 
as the one discussed above, it would be of value to conduct blood 
analyses on all subjects in order to determine whether or not the 
EHF thresholds are directly related to the levels of serum lipids 
and other blood clotting components.
CHAPTER V 
SUMMARY AND CONCLUSIONS
This study was undertaken to investigate the possible rela­
tionship of Extra-High Frequency (EHF) pure tone thresholds to the 
use of oral contraceptives. The major hypothesis of the project was 
that women using oral contraceptives would demonstrate significantly 
higher thresholds for the EHFs than women who have never used oral 
contraceptives. The procedure involved the determination of aud­
itory thresholds of 42 subjects for the frequencies lOK, 12K, 14K, 
16K, and 18K Hz using automatic audiometry. The subjects were 
divided into three groups as f ollows : (1) 14 women aged 18-28 
years who have used oral contraceptives continuously for the last 
four or more years; (2) 14 women aged 18-28 years who have used oral 
contraceptives continuously for the last one-three years; (3) 14 
women aged 18-28 years who have never used oral contraceptives.
All subjects reported no history of excessive noise exposure and 
were required to pass a pure tone screening test bilaterally for 
the frequencies 2K, 4K, and 6K Hz. In addition, subjects were con­
trolled for (a) smoking, (b) medically restrictive diets such as 
low cholesterol or low sugar, (c) reported elevated blood pressure, 
and (d) ototoxic drug usage.
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The results of the study Indicated no significant differ­
ences in EHF pure tone thresholds between subjects using oral con­
traceptives and control subjects for any of the five Extra-High 
frequencies tested. There was a general but statistically non­
significant trend for the group of women using oral contraceptives 
for the last four or more years to have higher mean EHF thresholds 
than the group of women using oral contraceptives for the last 
one-three years; however, neither group of oral contraceptive users 
demonstrated consistently higher EHF thresholds than the control 
group. The differences in results between this study and previous 
investigations of the relationship of EHF thresholds to elevated 
blood lipids and various blood clotting components were discussed 
in terms of the differences in subject selection and experimental 
procedures. It was concluded that the use of oral contraceptives 
does not appear to significantly affect, as a group, the EHF hearing 
acuity of normal women aged 18-28 years. Suggestions were made con­
cerning possible future investigations of the relationship of EHF 
thresholds to the use of oral contraceptives.
B I B L I O G R A P H Y
BIBLIOGRAPHY
Allison, R. and Roth G. "Central and Peripheral Vascular Effects
During Cigarette Smoking," Archives of Environmental Health, 
70, 1969. pp. 189-198.
Altshuler, Morton and Welsh, Oliver. "Sudden Hearing Loss With
Spontaneous Recovery," Journal of Speech and Hearing Dis- 
orders, 31, 1966. pp. 166-171.
Aronson, H., Magora, P., and Schenker, J. "Effects of Oral Con­
traceptives on Blood Viscosity," American Journal of Obstet­
rics and Gynecology, 110, 1971. pp. 997-1001.
Axelsson, Alf. "The Vascular Anatomy of the Cochlea in the
Guinea Pig and in Man," Acta Otolaryngologica, Supplement 
243, 1968.
Boffa, P. S. Pathological Effects of Oral Contraceptives. New 
York: MSS Information Corporation, 1973.
Bolton, C. H. , Hampton, J. R. , and Mitchell, J. R. "Effects of 
Oral Contraceptive Agents on Platelets and Plasma- 
Phospholipids," Lancet, I, 1968. pp. 1336-1341.
Brody, S., Kirstell, Jr., Nilsson, L., and Svanborg, A. "The
Effects of Some Ovulation Inhibitors on the Different Plasm 
Lipid Fractions," Acta Medica Scandinavica, 183, 1968, 
pp. 1-7.
Constantinides, P. "Endothelial Injury in the Pathogenesis of
Arteriosclerosis," Advances in Experimental Medicine and 
Biology, Ed. by Stewart Wold. New York: Plenum Press,
1971.
Cunningham, D. and Goetzinger, C. "Extra-High Frequency Hearing
Loss and Hyperlipidemia," Audiology, 33, 1974. pp. 470-484.
Davis, Hallowell and Silverman, S. Richard. Hearing and Deafness.
New York: Holt, Rinehart, and Winston, 1970.
de Alvarez, N . , Jahed, F. , and Spitalney, K. "The Influence of 
Oral Contraceptive Steroids on Serum Lipids," American 
Journal of Obstetrics and Gynecology, 116, 1973. pp. 727-749.
56
57
Diehl, H. Tobacco and Your Healtht The Smoking Controversy, New 
York: McGraw-Hill Book Company, 1969.
Donde, U. M. and Virkar, K, "The Effect of Contraceptive Steroids 
on Serum Lipids," American Journal of Obstetrics and Gyne­
cology, 123, 1975. pp. 736-741. .
Drettner, B., Hedstrand, H. , Klockhoff, I., and Ivedberg, A.
"Cardiovascular Risk Factors and Hearing Loss," Acta 
Otolaryngologica, 79, 1975. pp. 366-371.
Falbe-Hansen, J. and Thomsen, E. "Histochemical Studies on
Glyocogen in the Cochlea of the Normal Guinea Pig," Acta 
Otolaryngologica, 56, 1963. pp. 429-437.
Finnerty, F. and Linde, S. High Blood Pressure. New York: The
David McKay Company, 1975.
Fisch, I. R. and Freedman, S. "Oral Contraceptives, ABO Blood 
Groups, and In Vitro Fibrin Formation," Obstetrics and 
Gynecology, 46, 1975. pp. 473-480.
Fisch, L. "The Selective and Differential Vulnerability of the 
Auditory System," Sensorineural Hearing Loss. Edited by 
GEW Wolstenholme and Julie Knight. London: J. & A.
Churchill, 1970.
Fowler, E. P. "Presbycusis— The Aging Ear," Annals of Otology, 
Rhinology, and Laryngology, 68, 1959. pp. 764-776.
Hallberg, Eric. "Sudden Deafness and Its Relation to Atherosclero­
sis," J o u r n ^  JËhâ ASÊlASHl 165, 1957,
pp. 1649-1652.
Ham, J. and Rose, R. "Platelet Adhesiveness and Lipoprotein
Lipase Activity in Controls and in Subjects Taking Oral 
Contraceptives," American Journal of Obstetrics and 
Gynecology, 105, 1969. pp. 628-631.
Hansen, Carl. "Perceptive Hearing Loss and Arterial Hypertension," 
Archives of Otolaryngology, 87, 1968. pp. 119-122.
Hawkins, Joseph E. "The Role of Vasoconstriction in Noise-Induced 
Hearing Loss," Annals of Otology, Rhinology, and 
Laryngology, 80, 1971. pp. 903-913.
_________, Johnsson, L., and Preston, R. "Cochlear Microvascu­
lature in Normal and Damaged Ears," Laryngoscope, 82, 1972. 
pp. 1091-1103.
58
Hopkinson, N. and Lindberg, R. "Relevance of Vascular Disorders 
To Audiological Findings," Journal of Speech and Hearing 
Disorders, 36, 1971. pp. 447-466.
Irey, N. and Norris, H. "Intimai Vascular Lesions Associated With 
Female Reproductive Steroids," Archives of Pathology, 96,
1973. pp. 227-234.
Ismail, A., Corrigan, D., MacLeod, D., Anderson, N . , Kasten, R. ,
and Elliot, P. "Biophysiological and Audiological Variables 
in Adults," Archives of Otolaryngology, 97, 1973. pp. 447-451.
Jaffe, B. "Sudden Deafness," Archives of Otolaryngology  ̂ 86, 1967^ 
pp. 55-60.
"Sudden Deafness— A Local Manifestation of Systemic
Disorders," Laryngoscope, 80, 1970. pp. 788-801.
_________  and Penner, J. "Sudden Deafness Associated With Hyper­
coagulation," American Academy of Ophthalomology and Oto­
laryngology Transactions, 72, 1968. pp. 774-778.
Johnsson, L. and Hawkins, J. "Striai Atrophy in Clinical and Ex­
perimental Deafness," Laryngoscope, 82, 1972a. pp. 1105- 
1125.
 . "Vascular Changes in the Human Inner Ear Associated
With Aging," Annals of Otology, Rhinology, and Laryngology, 
81, 1972b. pp. 364-376.
Kirikae, I., Nomura, Y., and Hiraide, F. "The Capillary in the 
Human Cochlea," Acta Otolaryngologica, 67, 1969.
pp. 1—8.
Lawrence, M. "Effects of Interference With Terminal Blood Supply 
on the Organ of Corti," Laryngoscope, 76, 1966. pp. 1318- 
1337.
_________ . "Circulation in the Capillaries of the Basilar Membrane,"
Laryngoscope, 80, 1970. pp. 1364-1375.
Podoshin, L., Fradis, M., Pillar, T., and Zisman, D. "Senso-
Neural Hearing Loss As an Expression of Atherosclerosis in 
Young People," Eye, Ear, Nose, and Throat Monthly, 54, 1975. 
pp. 18-23.
Polus, K. "The Problem of Vascular Deafness," Laryngoscope, 82,
1972. pp. 24-27.
59
Rosen, S, "Presbycusis Study of a Relatively Noise-Free Population 
in the Sudan," Annals of Otology, Rhinology, and Laryngology, 
71, 1962. pp. 727-743.
_________ , and Olin, P. "Hearing Loss and Coronary Heart Disease,"
Archives of Otolaryngology. 82, 1965. pp. 236-247,
_________ , Olin P., and Rosen, H. "Dietary Prevention of Hearing
Loss," Acta Otolaryngologica, 70, 1970a. pp. 242-247.
, Piaster, D., El-Mofty, A., and Rosen, H. "High Frequency
Audiometry in Presbycusis," Archives of Otolaryngology, 79, 
1964. pp. 18-32.
_________, Preobrajensky, N . , Khechinashvili, S., Glazunov, P.,
Kipshidze, N. , and Rosen, H. "Epidemiologic Hearing Studies 
in the U.S.S.R.," Archives of Otolaryngology, 91, 1970b. 
pp. 424-428.
_________ and Rosen, H. "High-Frequency Studies in School Children
in Nine Countries," Laryngoscope, 81, 1970c. pp. 1007-1013.
Sachs, B., WoIfman, L., and Herzig, N. "Plasma Lipid and Lipo­
protein Alterations During Oral Contraceptive Administra­
tions," Obstetric^ a ^  Gynecology, 34, 1969. pp. 530-535.
Salhanick, H., Kipelis, D., and Vande Wiele, R. Metabolic Effects 
of Gonadal Hormones and Contraceptive Steroids. New York: 
Plenum Press, 1969.
Saunders, W. "Sudden Deafness and Its Several Treatments," 
Laryngoscope, 82, 1972. pp. 1206-1213.
Schenker, J. , Pinson, A . , and Polishuk, W. "The Effect of Oral
Contraceptives on Serum Lipids," Fertility and Sterility,
22, 1971. pp. 604-607.
Shulman, A. "The Pill, Hearing, and Balance," Highlights, 53,
1974. pp. 4-6.
Spellacy, W. N . , Buhi, W . , Birk, S., and Cabal, R. "Effects of 
Estrogen, Progesterone, Oral Contraceptives, and Intra­
uterine Devices on Fasting Triglyceride and Insulen Levels," 
Fertility and Sterility, 24, 1973. pp. 178-183.
Spencer, James. "Hyperlipoproteinemias in the Etiology of Inner 
Ear Disease," Laryngoscope, 83, 1973. pp. 639-678.
Stokes, T. and Wynn, V. "Serum Lipids in Women on Oral Contra­
ceptives," Lancet, II, 1971. pp. 677-680.
60
Vassalo, L., Sataloff, J., and Menduke, H. "Very High Frequency 
Audiometric Technique," Archives of Otolaryngology, 88, 
1968. pp. 251-253.
Wilbur, Laura Ann. "Calibration: Pure Tone, Speech, and Noise
Signals," Handbook of Clinical Audiology. Edited by Jack 
Katz. Baltimore: The Williams and Wilkins Co., 1972,
Wynn, V., Doar, J., and Mills, G. "Some Effects of Oral Contra­
ceptives on Serum Lipid and Lipoprotein Levels," Lancet,
II, 1966. pp. 720-723.
_________ . "Fasting Serum Triglyceride, Cholesterol, and Lipo­
protein Levels During Oral Contraceptive Therapy," Lancet, 
II, 1969. pp. 756-769.
Ygge, J., Brody, S., Korsan-Bengston, S., and Nilsson, L. "Changes 
in Blood Coagulation and Fibrinolysis in Women Receiving 
Oral Contraceptives," American Journal of Obstetrics and 
Gynecology, 104, 1969. pp. 87-98.
A P P E N D I X
61
INDIVIDUAL EHF THRESHOLDS (dB SPL) OF 
WOMEN USING ORAL CONTRACEPTIVES FOR 4 OR MORE YEARS
(GROUP A)^
RIGHT EAR LEFT EAR
s// lOK 12K 14K 16K 18K lOK 12K 14K 16K 18K
1. 25 36 43 60 85 20 41 34 63 85
2. 14 35 31 46 65 24 21 41 63 67
3. 23 49 45 72 78 22 28 54 57 94
4. 26 15 33 25 54 33 57 55 41 73
5. 25 20 31 62 77 22 29 44 52 76
6. 25 45 52 71 88 31 34 56 82 90
7. 30 51 29 34 59 32 24 60 63 58
8. 34 41 55 115 120 31 30 38 111 120
9. 33 39 57 60 78 29 51 44 28 53
10. 36 39 38 66 85 29 38 34 52 65
11. 32 53 38 43 76 37 32 38 51 54
12. 34 24 31 49 81 39 48 52 67 95
13. 32 45 64 59 86 32 52 48 85 90
14. 58 47 56 67 87 40 84 81 80 108
4The .reader is reifiin'ded that the actual threshold sound pressure 
levels present at the eardrums of the subjects will differ from the 
sound pressure levels listed in this Appendix due to certain ex­
perimental procedures. However, since this study involved a 
comparison of threshold sound pressure levels of two experimental 
groups with thresholds of a control group, and exactly the same test 
procedure was used for all 3 subject groups, the accuracy of these 
sound pressure level measurements is judged to be sufficient for 
purposes of this study. (See also the footnote on page 34 and dis­
cussion on page 50.)
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INDIVIDUAL EHF THRESHOLDS (dB SPL) OF 
WOMEN USING ORAL CONTRACEPTIVES FOR 1-3 YEARS
(GROUP B)
RIGHT EAR LEFT EAR
s// lOK 12K 14K 16K 18K lOK 12K 14K 16K 18K
1. 24 47 60 74 83 30 49 58 83 87
2. 26 39 41 68 85 31 48 47 77 97
3. 25 31 60 55 71 20 41 30 64 92
4. 30 35 32 46 48 25 45 37 59 60
5. 31 35 53 99 120 32 52 73 108 109
6. 22 36 25 28 65 13 31 33 34 67
7. 18 36 18 41 59 11 14 22 24 51
8. 31 48 46 30 76 38 38 32 37 103
9. 25 45 32 41 69 25 45 29 52 65
10. 23 42 35 58 72 27 36 30 70 76
11. 34 46 52 55 70 43 65 64 55 63
12. 30 43 37 50 61 22 33 26 43 65
13. 23 51 40 63 97 29 26 36 58 94
14. 38 57 34 37 95 22 32 39 48 83
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INDIVIDUAL EHF THRESHOLDS (dB SPL) OF 
WOMEN WHO HAVE NEVER USED ORAL CONTRACEPTIVES
(GROUP C)
RIGHT EAR LEFT EAR
s# lOK 12K 14K 16K 18K lOK 12K 14K 16K 18K
1. 20 25 52 68 87 31 56 47 74 95
2. 38 52 68 88 104 31 26 68 99 98
3. 32 40 38 64 98 34 43 44 87 107
4. 24 26 42 29 74 25 40 21 44 82
5. 34 64 51 80 82 27 36 31 63 78
6. 33 41 39 48 88 34 50 42 45 91
7. 22 47 38 46 74 25 36 32 37 83
8. 30 57 55 47 57 24 35 39 43 69
9. 34 52 33 50 88 30 33 32 49 84
10. 31 43 67 81 108 34 57 60 81 105
11. 26 53 44 56 73 21 34 41 49 75
12. 26 54 33 51 73 28 44 38 47 77
13. 34 43 46 58 69 33 37 38 47 54
14. 30 40 52 89 77 33 59 85 97 106
